Related Experiment Video
Updated: Aug 23, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Inflammatory Hot Phases in Arrhythmogenic Cardiomyopathy: A Dynamic Electrophysiologic Substrate Beyond Scar
Mehrdad Zarghami1, Neda Dianati Maleki2, Sajieh Naddaf3
1Department of Internal Medicine, Jamaica Hospital Medical Center, Queens, New York, USA; Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Insights
Arrhythmogenic cardiomyopathy may involve "hot phases" with inflammation mimicking myocarditis, accelerating injury. Current management focuses on standard care, with immunomodulatory therapy still under investigation.
Area of Science:
- Cardiology
- Genetics
- Immunology
Background:
- Arrhythmogenic cardiomyopathy (ACM) is traditionally viewed as a progressive inherited heart condition.
- Recent evidence suggests episodic inflammatory
- hot phases
- potentially mimicking acute myocarditis and worsening ACM progression.
Purpose of the Study:
- To review evidence supporting the ACM hot-phase paradigm.
- To propose a structured approach for evaluating suspected ACM hot phases.
- To discuss current and future therapeutic strategies.
Main Methods:
- Synthesis of mechanistic, imaging, genetic, and electrophysiologic data.
- Review of cardiac magnetic resonance (CMR) tissue characterization techniques (T2 mapping, LGE).
- Analysis of proposed pathomechanisms including inflammasome activation and immune responses.
Main Results:
- The ACM hot phase is characterized by active inflammation and edema, distinct from chronic fibrofatty scar.
- CMR imaging can differentiate active inflammation from chronic changes.
- Proposed mechanisms involve genetic predisposition, immune system activation, and cellular stress pathways.
Conclusions:
- The ACM hot-phase concept offers a new framework for understanding disease progression.
- Suspected hot phases warrant comprehensive evaluation including genetic testing and family screening.
- Standard ACM care is recommended, while immunomodulatory therapies require further research.
Abstract:
Arrhythmogenic cardiomyopathy (ACM) has traditionally been conceptualized as a progressive inherited cardiomyopathy characterized by fibrofatty replacement and ventricular arrhythmias. Emerging clinical and translational evidence suggests that selected patients experience episodic inflammatory exacerbations, or "hot phases," that mimic acute myocarditis and may accelerate myocardial injury, scar formation, and arrhythmic vulnerability. Proposed mechanisms include desmosomal instability, maladaptive mechanotransduction, inflammasome activation, cytokine signaling, and humoral immune reactivity, including anti-desmoglein-2 responses. Cardiac magnetic resonance tissue characterization, particularly T2 mapping combined with late gadolinium enhancement, may help distinguish active edema from chronic scar and support genotype-informed phenotyping. This review synthesizes mechanistic, imaging, genetic, and electrophysiologic evidence for the ACM hot-phase paradigm and proposes a structured approach to evaluation. At present, suspected hot phase should prompt exclusion of mimics, rhythm surveillance, genotype assessment, family screening, and standard ACM risk-based care, whereas immunomodulatory therapy remains investigational or context-dependent.
Related Concept Videos
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Myocarditis I: Introduction
Electrophysiology of Normal Cardiac Rhythm
Mechanism of Cardiac Arrhythmias
Myocarditis II: Clinical Features and Diagnostic Tests
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
